These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 30173314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.
    Liu T, Li S, Wang M, Sun Q, Chen G.
    Patient; 2020 Oct; 13(5):537-555. PubMed ID: 32382953
    [Abstract] [Full Text] [Related]

  • 3. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.
    Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Akbari Sari A.
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):89-96. PubMed ID: 30173585
    [Abstract] [Full Text] [Related]

  • 4. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.
    Yousefi M, Nahvijou A, Sari AA, Ameri H.
    Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752
    [Abstract] [Full Text] [Related]

  • 5. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N, Aletras VH, Paliouras D, Niakas D.
    Value Health; 2009 May; 12(8):1151-7. PubMed ID: 19558372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
    Franken MD, de Hond A, Degeling K, Punt CJA, Koopman M, Uyl-de Groot CA, Versteegh MM, van Oijen MGH.
    Health Qual Life Outcomes; 2020 Jul 20; 18(1):240. PubMed ID: 32690011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
    Doble B, Lorgelly P.
    Qual Life Res; 2016 Apr 20; 25(4):891-911. PubMed ID: 26391884
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
    Meunier A, Soare A, Chevrou-Severac H, Myren KJ, Murata T, Longworth L.
    Appl Health Econ Health Policy; 2022 Jan 20; 20(1):119-131. PubMed ID: 34554442
    [Abstract] [Full Text] [Related]

  • 14. Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia.
    Abdin E, Chong SA, Seow E, Verma S, Tan KB, Subramaniam M.
    Qual Life Res; 2019 Jan 20; 28(1):177-186. PubMed ID: 30382480
    [Abstract] [Full Text] [Related]

  • 15. Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas.
    Xu RH, Wong ELY, Jin J, Dou Y, Dong D.
    Eur J Health Econ; 2020 Dec 20; 21(9):1363-1373. PubMed ID: 32960388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.
    Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Akbari Sari A.
    J Gastrointest Cancer; 2020 Mar 20; 51(1):196-203. PubMed ID: 30977049
    [Abstract] [Full Text] [Related]

  • 19. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A, Green C, Telford C, Zajicek J, Wright D.
    Value Health; 2012 Dec 20; 15(8):1084-91. PubMed ID: 23244811
    [Abstract] [Full Text] [Related]

  • 20. Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets.
    Lamu AN.
    Eur J Health Econ; 2020 Aug 20; 21(6):903-915. PubMed ID: 32300999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.